Unhealthy white matter connectivity, cognition, and racialization in older adults

Alzheimers Dement. 2024 Mar;20(3):1483-1496. doi: 10.1002/alz.13494. Epub 2023 Oct 12.

Abstract

Introduction: White matter hyperintensities (WMH) may promote clinical Alzheimer's disease (AD) disparities between Black American (BA) and non-Hispanic White (nHW) populations. Using a novel measurement, unhealthy white matter connectivity (UWMC), we interrogated racialized group differences in associations between WMH in AD pathology-affected regions and cognition.

Methods: UWMC is the proportion of white matter fibers that pass through WMH for every pair of brain regions. Individual regression models tested associations of UWMC in beta-amyloid (Aβ) or tau pathology-affected regions with cognition overall, stratified by racialized group, and with a racialized group interaction.

Results: In 201 older adults ranging from cognitively unimpaired to AD, BA participants exhibited greater UWMC and worse cognition than nHW participants. UWMC was negatively associated with cognition in 17 and 5 Aβ- and tau-affected regions, respectively. Racialization did not modify these relationships.

Discussion: Differential UWMC burden, not differential UWMC-and-cognition associations, may drive clinical AD disparities between racialized groups.

Highlights: Unhealthy white matter connectivity (UWMC) in Alzheimer's disease (AD) pathology-affected brain regions is associated with cognition. Relationships between UWMC and cognition are similar between Black American (BA) and non-Hispanic White (nHW) individuals. More UWMC may partially drive higher clinical AD burden in BA versus nHW populations. UWMC risk factors, particularly social and environmental, should be identified.

Keywords: cerebral small vessel disease; cerebrovascular lesions; cognition; connectome; racialization.

MeSH terms

  • Aged
  • Alzheimer Disease* / complications
  • Amyloid beta-Peptides / metabolism
  • Brain / metabolism
  • Cognition
  • Cognitive Dysfunction* / complications
  • Humans
  • Magnetic Resonance Imaging
  • White Matter* / metabolism

Substances

  • Amyloid beta-Peptides